| J0491 | Injection, anifrolumab-fnia, 1 mg | 44,740 | $10 | $581.6K |
| J3262 | Injection, tocilizumab, 1 mg | 57,830 | $10 | $289.1K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 2,150 | $90 | $193.5K |
| J9312 | Injection, rituximab, 10 mg | 2,410 | $60 | $151.8K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 37,200 | $1 | $148.8K |
| J0897 | Injection, denosumab, 1 mg | 7,920 | $20 | $142.6K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 510 | $100 | $50K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 670 | $60 | $40K |
| 86235 | The lab analyst performs an assay to evaluate the patient’s serum for each antibody to an extractable nuclear antigen, also called ENA. Types of ENA antibodies include anti ribonuclear protein,… | 1,540 | $20 | $26.1K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 340 | $60 | $19.1K |